Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Cell Culture Media, Supplements, and Reagents
  4. Cell Culture Reagents, Antibiotics and Supplements
  5. Additional Cell Culture Reagents and Supplements
  6. MilliporeSigma™ Chemicon™ Recombinant Human Leukemia Inhibitory Factor Protein

MilliporeSigma™ Chemicon™ Recombinant Human Leukemia Inhibitory Factor Protein

Catalog No. LIF1005 Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
10 μg
5 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
LIF1005 5 μg
LIF1010 10 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. LIF1005 Supplier MilliporeSigma™ Supplier No. LIF1005
Only null left
Add to Cart
Add to Cart

Description

biologically active and suitable for cell culture applications.

Leukaemia inhibitory factor is a cytokine that induces macrophage differentiation. Neurotransmitters and neuropeptides, well known for their role in the communication between neurons, are also capable of activating monocytes and macrophages and inducing chemotaxis in immune cells. LIF signals through different receptors and transcription factors. LIF in conjunction with BMP2 acts in synergy on primary fetal neural progenitor cells to induce astrocytes.
TRUSTED_SUSTAINABILITY

Specifications

Content And Storage 2- 8°C for 6 - 12 months
For Use With (Application) Cell culture
Quantity 5 μg
Source E. coli
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.